Sign in

CIK 0001626878

  • Non-accelerated filer
  • Smaller reporting company

XBiotech Inc.

Sign in to watch
Ticker
XBIT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 512-386-2900
Business address
5217 WINNEBAGO LANE, AUSTIN, TX, 78744
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy 10% owner bought 1,200,000 shares at $8.25 ($9,900,000)
  7. 4 Open-market buy 10% owner bought 16,426 shares at $7.91 ($129,930)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Chief Scientific Officer sold 4,500 shares at $10.00 ($45,000)
  11. 4/A Open-market buy Director bought 44,838 shares at an average $5.52 ($247,369)
  12. 4 Open-market buy 10% owner bought 45,574 shares at an average $8.14 ($370,835)
  13. 4 Open-market buy 10% owner bought 112,300 shares at an average $9.25 ($1,039,049)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Director bought 29,802 shares at an average $5.73 ($170,799)
  16. 4 Exercise or conversion Chief Executive Officer acquired 50,000 shares (option exercise)
  17. 4 Open-market buy Director bought 2,900 shares at an average $3.74 ($10,842)
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale Director sold 385,000 shares at $3.00 ($1,155,000)
  20. 4 Open-market sale Director sold 17,634 shares at $3.05 ($53,798)

Page 5 of 9 · 176 filings